Cargando…

Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis

INTRODUCTION: Proton beam therapy (PBT) is known to be an effective locoregional treatment for hepatocellular carcinoma (HCC). However, few comparative studies in treatment-naïve cases have been reported. The aim of this study was to compare the survival outcomes of PBT with those of radiofrequency...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sekino, Yuta, Tateishi, Ryosuke, Fukumitsu, Nobuyoshi, Okumura, Toshiyuki, Maruo, Kazushi, Iizumi, Takashi, Numajiri, Haruko, Mizumoto, Masashi, Minami, Tatsuya, Nakagomi, Ryo, Sato, Masaya, Asaoka, Yoshinari, Nakagawa, Hayato, Hayata, Yuki, Fujiwara, Naoto, Shiina, Shuichiro, Koike, Kazuhiko, Sakurai, Hideyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561322/ https://www.ncbi.nlm.nih.gov/pubmed/37817755 http://dx.doi.org/10.1159/000528537

Ejemplares similares

Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation
por: Uchino, Koji, et al.
Publicado: (2018)

Frequency of and Predictive Factors for Vascular Invasion after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Asaoka, Yoshinari, et al.
Publicado: (2014)

Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics
por: Nakagomi, Ryo, et al.
Publicado: (2021)

Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients
por: Minami, Tatsuya, et al.
Publicado: (2015)

Frequency, Risk Factors and Survival Associated with an Intrasubsegmental Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Tateishi, Ryosuke, et al.
Publicado: (2013)

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer
por: Iizumi, Takashi, et al.
Publicado: (2021)

Proton beam therapy for liver metastases from gastric cancer
por: Fukumitsu, Nobuyoshi, et al.
Publicado: (2017)

Three cases of hepatocellular carcinoma treated 4 times with proton beams
por: Murakami, Motohiro, et al.
Publicado: (2020)

An Analysis of Vertebral Body Growth after Proton Beam Therapy for Pediatric Cancer
por: Baba, Keiichiro, et al.
Publicado: (2021)

Light flashes during proton and photon radiotherapy: A multicenter prospective observational study
por: Mizumoto, Masashi, et al.
Publicado: (2021)

Abnormal sensation during total body irradiation: a prospective observational study
por: Mizumoto, Masashi, et al.
Publicado: (2022)

Olfactory Sensations During Proton and Photon Radiotherapy: A Multicenter Prospective Observational Study
por: Mizumoto, Masashi, et al.
Publicado: (2022)

Light flash and odor during proton beam therapy for pediatric patients: a prospective observational study
por: Mizumoto, Masashi, et al.
Publicado: (2022)

IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal
por: Okushin, Kazuya, et al.
Publicado: (2012)

Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinoma
por: Tsai, Yu-Lun, et al.
Publicado: (2020)

Registration error of the liver CT using deformable image registration of MIM Maestro and Velocity AI
por: Fukumitsu, Nobuyoshi, et al.
Publicado: (2017)

Long‐term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma
por: Fukuda, Kuniaki, et al.
Publicado: (2017)

Long-term follow up of a patient with a recurrent desmoid tumor that was successfully treated with proton beam therapy: A case report and literature review
por: Sawada, Takuya, et al.
Publicado: (2020)

Photon or Proton Therapy for Adolescent and Young Adult Tumors Focused on Long-Term Survivors
por: Mizumoto, Masashi, et al.
Publicado: (2021)

Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals
por: Fukumoto, Tsuyoshi, et al.
Publicado: (2022)

Changes in Risk of Immediate Adverse Reactions to Iodinated Contrast Media by Repeated Administrations in Patients with Hepatocellular Carcinoma
por: Fujiwara, Naoto, et al.
Publicado: (2013)

Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation
por: Li, Yinuo, et al.
Publicado: (2022)

Retrospective Analysis of the Areas Responsible for Light Flash and Odor During Proton Beam Therapy and Photon Therapy
por: Oshiro, Yoshiko, et al.
Publicado: (2023)

Impact of RhoA overexpression on clinical outcomes in cervical squamous cell carcinoma treated with concurrent chemoradiotherapy
por: Tanaka, Keiichi, et al.
Publicado: (2020)

Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy
por: Shimizu, Shosei, et al.
Publicado: (2019)

Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma
por: Iizumi, Takashi, et al.
Publicado: (2021)

The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in esophagogastric cancer patients
por: Yamaguchi, Hisashi, et al.
Publicado: (2023)

Radiation Therapy for Grade 3 Gliomas: Correlation of MRI Findings With Prognosis
por: Mizumoto, Masashi, et al.
Publicado: (2021)

A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma
por: Nakamura, Masatoshi, et al.
Publicado: (2018)

Improved liver function in patients with cirrhosis due to chronic hepatitis C virus who achieve sustained virologic response is not accompanied by increased liver volume
por: Wake, Taijiro, et al.
Publicado: (2020)

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma
por: Ikeda, Masafumi, et al.
Publicado: (2014)

Analysis of the cost‐effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan
por: Hiroshima, Yuichi, et al.
Publicado: (2023)

Radiotherapy for liver cancer
por: Fukumitsu, Nobuyoshi, et al.
Publicado: (2017)

Proton Beam Therapy for a Patient with a Giant Thymic Carcinoid Tumor and Severe Superior Vena Cava Syndrome
por: Sugawara, Kaori, et al.
Publicado: (2014)

Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan
por: Oshiro, Yoshiko, et al.
Publicado: (2021)

Machine-learning Approach for the Development of a Novel Predictive Model for the Diagnosis of Hepatocellular Carcinoma
por: Sato, Masaya, et al.
Publicado: (2019)

Proton beam therapy for hepatocellular carcinoma with bile duct invasion
por: Iizumi, Takashi, et al.
Publicado: (2023)

Transitions of Liver and Biliary Enzymes during Proton Beam Therapy for Hepatocellular Carcinoma
por: Sumiya, Taisuke, et al.
Publicado: (2020)

Proton beam therapy for a giant hepatic hemangioma: A case report and literature review
por: Shimizu, Shosei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9t90u9apnpnvdan9frnb95ka7m